Matches in Nanopublications for { ?s ?p "[The high Ile(157)--> Thr(157)mutation frequency (6.5%) observed in healthy controls and the lack of other mutations suggest that CHK2 does not contribute significantly to the hereditary breast cancer or LFL-associated breast cancer risk, at least not in the Finnish population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- assertion description "[The high Ile(157)--> Thr(157)mutation frequency (6.5%) observed in healthy controls and the lack of other mutations suggest that CHK2 does not contribute significantly to the hereditary breast cancer or LFL-associated breast cancer risk, at least not in the Finnish population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The high Ile(157)--> Thr(157)mutation frequency (6.5%) observed in healthy controls and the lack of other mutations suggest that CHK2 does not contribute significantly to the hereditary breast cancer or LFL-associated breast cancer risk, at least not in the Finnish population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The high Ile(157)--> Thr(157)mutation frequency (6.5%) observed in healthy controls and the lack of other mutations suggest that CHK2 does not contribute significantly to the hereditary breast cancer or LFL-associated breast cancer risk, at least not in the Finnish population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP324325.RACNvn7y2wRA2t7Td_KY83oocLgu6Hqu1e_hzQ5vDp9i0130_assertion description "[The high Ile(157)--> Thr(157)mutation frequency (6.5%) observed in healthy controls and the lack of other mutations suggest that CHK2 does not contribute significantly to the hereditary breast cancer or LFL-associated breast cancer risk, at least not in the Finnish population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP324325.RACNvn7y2wRA2t7Td_KY83oocLgu6Hqu1e_hzQ5vDp9i0130_provenance.
- NP324327.RAggZnABeIx7-1s0eDN5AeYSslrtxIO18IDLTQEfc1FMo130_assertion description "[The high Ile(157)--> Thr(157)mutation frequency (6.5%) observed in healthy controls and the lack of other mutations suggest that CHK2 does not contribute significantly to the hereditary breast cancer or LFL-associated breast cancer risk, at least not in the Finnish population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP324327.RAggZnABeIx7-1s0eDN5AeYSslrtxIO18IDLTQEfc1FMo130_provenance.
- NP863079.RAOQdfWoMDFSpWGeY4W9drtP7QbXXoqbUWoEVrjLjrQ-g130_assertion description "[The high Ile(157)--> Thr(157)mutation frequency (6.5%) observed in healthy controls and the lack of other mutations suggest that CHK2 does not contribute significantly to the hereditary breast cancer or LFL-associated breast cancer risk, at least not in the Finnish population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP863079.RAOQdfWoMDFSpWGeY4W9drtP7QbXXoqbUWoEVrjLjrQ-g130_provenance.
- NP324332.RA4Gq8-5wU_5cwQKm3PLJTlf7V0NW9f9Nf-CmduwoYAlY130_assertion description "[The high Ile(157)--> Thr(157)mutation frequency (6.5%) observed in healthy controls and the lack of other mutations suggest that CHK2 does not contribute significantly to the hereditary breast cancer or LFL-associated breast cancer risk, at least not in the Finnish population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP324332.RA4Gq8-5wU_5cwQKm3PLJTlf7V0NW9f9Nf-CmduwoYAlY130_provenance.